secwatch / observer

8-K filed June 2, 2026, 3:35 PM ET ticker PDSB CIK 0001472091

regulatory confidence high sentiment positive materiality 0.65

PDS Biotech regains Nasdaq minimum bid price compliance as of June 2, 2026

PDS Biotechnology Corp

Nasdaq notified PDS Biotech on June 2, 2026 that it regained compliance with the $1.00 minimum bid price rule.
The company had fallen below $1.00 for 30 consecutive business days, triggering a deficiency letter on Feb 25, 2026.
Nasdaq has closed the matter; no further compliance actions required for this issue.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001140361-26-023698
form_type: 8-K
ticker: PDSB
cik: 0001472091
company_name: PDS Biotechnology Corp
filed_at: 2026-06-02T19:35:05+00:00
discovered_at: 2026-06-02T19:36:00.589808+00:00
generated_at: 2026-06-02T19:36:07.202296+00:00
sec_items: ["8.01"]
event_type: regulatory
sentiment: positive
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001140361-26-023698
json_url: https://secwatch.observer/filing/0001140361-26-023698.json
markdown_url: https://secwatch.observer/filing/0001140361-26-023698.md
text_url: https://secwatch.observer/filing/0001140361-26-023698.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/0001140361-26-023698-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/ef20075449_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

MNKD

FDA approves Afrezza for pediatric diabetes patients ages 6+

MANNKIND CORP June 2, 2026, 8:00 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

VERA

Vera Therapeutics announces FDA alignment on earlier eGFR analysis for atacicept; results expected Q3 2026

Vera Therapeutics, Inc. June 2, 2026, 7:05 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

TXNM

TXNM subsidiaries: TNMP rate settlement with $20.5M storm rider, PNM resource plan with 1.65 GW renewables

TXNM ENERGY INC June 1, 2026, 5:54 PM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

LESL

Leslie's regains Nasdaq compliance for minimum market value of publicly held shares

Leslie's, Inc. June 1, 2026, 4:28 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

VYGR

FDA clears IND for VY1706, Voyager's tau-silencing gene therapy for Alzheimer's

Voyager Therapeutics, Inc. June 1, 2026, 8:00 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

EXFY

Expensify regains Nasdaq minimum bid price compliance

Expensify, Inc. May 29, 2026, 5:15 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

SLXN

Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted

Silexion Therapeutics Corp May 29, 2026, 7:00 AM ET regulatory Items 3.03, 5.03, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing

RICHTECH ROBOTICS INC. May 28, 2026, 4:49 PM ET regulatory Items 3.01, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001140361-26-023698

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.